Bank Pictet & Cie (Europe)’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $901K | Sell |
25,000
-15,000
| -38% | -$540K | 0.02% | 136 |
|
2025
Q1 | $1.25M | Sell |
40,000
-10,000
| -20% | -$311K | 0.03% | 105 |
|
2024
Q4 | $1.28M | Hold |
50,000
| – | – | 0.03% | 103 |
|
2024
Q3 | $1.41M | Hold |
50,000
| – | – | 0.03% | 96 |
|
2024
Q2 | $1.32M | Hold |
50,000
| – | – | 0.03% | 96 |
|
2024
Q1 | $1.52M | Hold |
50,000
| – | – | 0.04% | 96 |
|
2023
Q4 | $1.4M | Hold |
50,000
| – | – | 0.04% | 131 |
|
2023
Q3 | $1.36M | Hold |
50,000
| – | – | 0.05% | 124 |
|
2023
Q2 | $1.54M | Hold |
50,000
| – | – | 0.05% | 125 |
|
2023
Q1 | $1.8M | Hold |
50,000
| – | – | 0.07% | 95 |
|
2022
Q4 | $1.98M | Sell |
50,000
-11,747
| -19% | -$464K | 0.1% | 85 |
|
2022
Q3 | $2.48M | Hold |
61,747
| – | – | 0.12% | 80 |
|
2022
Q2 | $2.6M | Hold |
61,747
| – | – | 0.12% | 76 |
|
2022
Q1 | $2.41M | Hold |
61,747
| – | – | 0.09% | 84 |
|
2021
Q4 | $2.46M | Hold |
61,747
| – | – | 0.08% | 85 |
|
2021
Q3 | $2.23M | Buy |
+61,747
| New | +$2.23M | 0.08% | 88 |
|